Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Withdrawn × Radiosurgery × Clear all

Phase

Phase 2 16 Phase NA 14 Phase 1/2 8 Phase 1 8 Phase EARLY_PHASE1 3 Phase 3 2 Phase 4 1

Status

Withdrawn 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Recurrence 1 Neoplasms 1 Neoplasm Metastasis 1 Glioblastoma 1

Interventions

Metformin 3 Letrozole 3 Sperm Injections, Intracytoplasmic 2 Progesterone 2 Lidocaine 2 Indocyanine Green 2 Gentamicins 2 Estradiol 2 Clomiphene 2 Bevacizumab 2 tirbanibulin 1 technetium Tc 99m nanocolloid 1 suvorexant 1 pomalidomide 1 pembrolizumab 1 pasireotide 1 nilotinib 1 methylnaltrexone 1 ledipasvir 1 ixazomib 1 gadofosveset trisodium 1 exemestane 1 dolutegravir 1 ceftolozane, tazobactam drug combination 1 abemaciclib 1 Zoledronic Acid 1 Vortioxetine 1 Venlafaxine Hydrochloride 1 Trimethoprim, Sulfamethoxazole Drug Combination 1 Toremifene 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05900908 2025-04-10

PATHWAyS

GT Medical Technologies, Inc.

Phase 4 Withdrawn

Glioblastoma, Neoplasm Metastasis, Neoplasms, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡